Migraine pain: Reflections against vasodilatation

Journal of Headache and Pain

Volumn 10, Issue 5, 2009, Pages 317-325

  Panconesi, Alessandro ^a,b   Bartolozzi, Maria Letizia ^a   Guidi, Leonello ^a  

^a Regional Health Authority   (Italy)

^b NONE   (Italy)

Author keywords

Calcitonin gene related peptide; Migraine; Migraine pathogenesis; Pain; Triptans; Vasodilatation

Indexed keywords

ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CARBACHOL; CILOSTAZOL; DIHYDROERGOTAMINE; DIPYRIDAMOLE; ERGOTAMINE; GLYCEROL NITRATE; GLYCERYL TRINITRATE; HISTAMINE; METHYSERGIDE; MORPHINE; OLCEGEPANT; OPIATE; PETHIDINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SILDENAFIL; SUMATRIPTAN; TRIPTAN DERIVATIVE;

ADJUVANT THERAPY; ANTINOCICEPTION; CLUSTER HEADACHE; DEPRESSION; DOSE RESPONSE; DROWSINESS; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG USE; DYSPHORIA; HEADACHE; HUMAN; MIGRAINE; NEUROGENIC INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REVIEW; SEDATION; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VASOCONSTRICTION; VASODILATATION;

BRAIN; CALCITONIN GENE-RELATED PEPTIDE; HUMANS; MIGRAINE DISORDERS; NEUROGENIC INFLAMMATION; PAIN; SEROTONIN; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 70349254110     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-009-0130-6     Document Type: Review

References (102)

1. Moskowitz MA (2007) Pathophysiology of headache - past and present. Headache 27(Suppl 1):S58-S63. doi: 10.1111/j.1526-4610.2007.00678.x
2. Parsons AA, Strijbos PJ (2003) The neuronal versus vascular hypothesis of migraine and cortical spreading depression. Curr Opin Pharmacol 3:73-77. doi: 10.1016/S1471-4892(02)00016-4
3. Edvinsson L, Hamel E (2002) Perivascular nerves in brain vessels. In: Edvinsson L, Krause DN (eds) Cerebral blood flow and metabolism, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 43-67
4. Edvinsson L, Uddman R (2005) Neurobiology in primary headaches. Brain Res Rev 48:438-456. doi: 10.1016/j.brainresrev.2004.09.007
5. Hargreaves R (2007) New migraine and pain research. Headache 47(Suppl 1):S26-S43. doi: 10.1111/j.1526-4610.2006.00675.x
6. Wolff HG (1963) Headache and other head pain. Oxford University Press, New York
7. Moskowitz MA (1984) The neurobiology of vascular head pain. Ann Neurol 16:157-186. doi: 10.1002/ana.410160202
8. Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193-196. doi: 10.1002/ ana.410230214
9. Durham PL (2006) Calcitonin gene-related peptide (CGRP) and migraine. Headache 46(Suppl 1):S3-S8. doi: 10.1111/j.1526-4610.2006.00483.x
10. Humphrey PPA (2007) The discovery of a new drug class for the acute treatment of migraine. Headache 47(Suppl 1):S10-S19. doi: 10.1111/ j.1526-4610.2007.00672.x
11. Sicuteri F (1976) Hypothesis: Migraine, a central biochemical dysnociception. Headache 16:145-159. doi: 10.1111/ j.1526-4610.1976.hed1604145.x
12. Sicuteri F, Del Bianco PL, Anselmi B (1979) Morphine abstinence and serotonin supersensitivity in man: Analogies with the mechanism of migraine? Psychopharmacology 65:205-209. doi: 10.1007/BF00433050
13. Sicuteri F (1987) Quasi-phantom head pain from functional deafferentation. Clin J Pain 3:63-80. doi: 10.1097/ 00002508-198703020-00001
14. Sullivan JT, Preston KL, Testa MP, Busch M, Jasinski DR (1992) Psychoactivity and abuse potential of sumatriptan. Clin Pharmacol Ther 52:635-642
15. Panconesi A, Franchi G, Anselmi B, Curradi C (1994) On the mechanism of sumatriptan side effects. In: Fusco BM, Giacovazzo M (eds) Unilateral headache: Focus on recent advances. RD Editori, Rome, pp 111-116
16. Dodick DW, Martin V (2004) Triptans and CNS side-effects: pharmacokinetic and metabolic mechanism. Cephalalgia 24:417-424. doi: 10.1111/j.1468-2982.2004.00694.x
17. Panconesi A, Sicuteri R (1997) Headache induced by serotonergic agonists-a key to the interpretation of migraine pathogenesis? Cephalalgia 17:3-14. doi: 10.1046/j.1468-2982.1997.1701003.x
18. Panconesi A, Pavone E, Vacca F, Vaiani M, Banfi R (2008) Triptans in the Italian population: A drug utilization study and a literature review. J Headache Pain 9:71-76. doi: 10.1007/s10194-008-0020-3
19. Humphrey PPA (2008) The discovery and development of the triptans, a major therapeutic breakthrough. Headache 48:685-687. doi: 10.1111/ j.1526-4610.2008.01097.x
20. Moskowitz MA (1991) The visceral organ brain: Implications for the pathophysiology of vascular head pain. Neurology 41:182-186
21. Geppetti P, Capone JG, Trevisani M, Nicoletti P, Zagli G, Tola MR (2005) CGRP and migraine: Neurogenic inflammation revisited. J Headache Pain 6:61-70. doi: 10.1007/s10194-005-0153-6
22. Villalon CM, Centurion D (2007) Cardiovascular responses produced by 5-hydroxytryptamine: A pharmacological update on the receptors/ mechanisms involved and therapeutic implications. Naunyn-Schmiedeberg's Arch Pharmacol 376:45-63. doi: 10.1007/s00210-007-0179-1
23. Markowitz S, Saito K, Moskowitz MA (1988) Neurogenically mediated plasma extravasation in dura mater: Effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 8:83-91. doi: 10.1046/j.1468-2982.1988.0802083.x
24. Tfelt-Hansen PC, Koehler PJ (2008) History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward. Cephalalgia 28:877-886. doi: 10.1111/j.1468-2982.2008.01578.x
25. Shields KG, Goadsby PJ (2006) Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target? Neurobiol Dis 23:491-501. doi: 10.1016/ j.nbd.2006.04.003
26. Jeong H-J, Chenu D, Johnson EE, Connor M, Vaughan CW (2008) Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain. doi: 10.1186/1744-8069-4-54
27. Levy D, Jakubowski M, Burstein R (2004) Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc Natl Acad Sci USA 101:4274-4279. doi: 10.1073/pnas.0306147101
28. Strassman AM, Levy D (2006) Response properties of dural nociceptors in relation to headache. J Neurophysiol 95:1298-1306. doi: 10.1152/ jn.01293.2005
29. Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI (2003) Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: Implications for the selective antimigraine action of triptans. J Neurosci 23:10988-10997
30. Bartsch T, Knight YE, Goadsby PJ (2004) Activation of 5-HT 1B/1D receptor in the periaqueductal gray inhibits nociception. Ann Neurol 56:371-381. doi: 10.1002/ana.20193
31. Nikai T, Basbaum AI, Ahn AH (2008) Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain 139:533-540. doi: 10.1016/j.pain.2008.06.002
32. Carmichael NME, Charlton MP, Dostrovsky JO (2008) Activation of the 5-HT 1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin. Pain 134:97-105. doi: 10.1016/ j.pain.2007.03.037
33. Vera-Portocarrero LP, Ossipov MH, King T, Porreca F (2008) Reversal of inflammatory and noninflammatory visceral pain by central or peripheral actions of sumatriptan. Gastroenterology 135:1369-1378. doi: 10.1053/ j.gastro.2008.06.085
34. Burstein R, Jakubowski M, Levy D (2005) Anti-migraine action of triptans is preceded by transient aggravation of headache caused by activation of meningeal nociceptors. Pain 115:21-28. doi: 10.1016/j.pain.2005.01.027
35. Visser WH, de Vriend RH, Jaspers NH, Ferrari MD (1996) Sumatriptan-nonresponders: A survey in 366 migraine patients. Headache 36:471-475. doi: 10.1046/j.1526-4610.1996.3608471.x
36. Panconesi A (2008) Serotonin and migraine: A reconsideration of the central theory. J Headache Pain 9:267-276. doi: 10.1007/s10194-008-0058-2
37. Ostfeld AM (1960) Migraine headache: Its physiology and biochemistry. JAMA 174:1188-1190
38. Kimball RW, Friedman AP, Vallejo E (1960) Effect of serotonin in migraine patients. Neurology 10:107-111
39. Anthony M, Hinterberger H, Lance JW (1967) Plasma serotonin in migraine and stress. Arch Neurol 16:544-552
40. Tfelt-Hansen P (2007) Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine: A comment. J Headache Pain 8:273-276. doi: 10.1007/s10194-007-0411-x
41. Edvinsson L (2004) Blockade of CGRP receptors in the intracranial vasculature: A new target in the treatment of headache. Cephalalgia 24:611-622. doi: 10.1111/j.1468-2982.2003.00719.x
42. Link AS, Kuris A, Edvinsson L (2008) Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. J Headache Pain 9:5-12. doi: 10.1007/s10194-008-0011-4
43. Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183-187. doi: 10.1002/ana.410280213
44. Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J, Szolcsanyi J, Vitrai J, Bagdy G (2003) NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461-470. doi: 10.1016/j.pain.2003.09.008
45. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54-61. doi: 10.1046/j.1468-2982.2002.00310.x
46. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110. doi: 10.1056/NEJMoa030505
47. Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM (2008) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304-1312. doi: 10.1212/01.WNL.0000286940.29755.61
48. Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58:561-568. doi: 10.1002/ana.20605
49. Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J (2005) BIBN4096BS antagonizes human a-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 77:202-213. doi: 10.1016/j.clpt.2004.10.001
50. Lassen LH, Jacobsen VB, Haderslev PA, Sperling B, Iversen HK, Olesen J, Tfelt-Hansen P (2008) Involvement of calcitonin gene-related peptide in migraine: Regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain 9:151-157. doi: 10.1007/ s10194-008-0036-8
51. Edvinsson ML, Edvinsson L (2008) Comparison of CGRP and NO responses in the human peripheral microcirculation of migraine and control subjects. Cephalalgia 28:563-566. doi: 10.1111/j.1468-2982.2008.01558.x
52. de Hoon JN, Smits P, Troost J, Struijker-Boudier HA, Van Bortel LM (2006) Forearm vascular response to nitric oxide and calcitonin gene-related peptide: Comparison between migraine patients and control subjects. Cephalalgia 26:56-63. doi: 10.1111/j.1468-2982.2005.00993.x
53. Hansen JM, Thomsen LL, Olesen J, Ashina M (2008) Calcitonin gene related peptide does not cause the familial hemiplegic migraine phenotype. Neurology 71:841-847. doi: 10.1212/01.wnl.0000325482.64106.3f
54. Schoonman GG, van der Grond J, Kortmann C, van der Geest RJ, Terwindt GM, Ferrari MD (2008) Migraine headache is not associated with cerebral or meningeal vasodilation - a 3T magnetic resonance angiography study. Brain 131:2192-2200. doi: 10.1093/brain/awn094
55. Olesen J, Iversen HK, Thomsen LL (1993) Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain. NeuroReport 4:1027-1030
56. Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120:157-171. doi: 10.1016/ j.pharmthera.2008.08.003
57. Kruuse C, Thomsen LL, Jacobsen TB, Olesen J (2002) The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow or blood velocity, but nevertheless induces headache in healthy subjects. J Cereb Blood Flow Metab 22:1124-1131. doi: 10.1097/00004647-200209000-00010
58. Kruuse C, Thomsen LL, Birk S, Olesen J (2003) Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain 126:241-247. doi: 10.1093/brain/awg009
59. Kruuse C, Lassen LH, Iversen HK, Oestergaard S, Olesen J (2006) Dipyridamole may induce migraine in patients with migraine without aura. Cephalalgia 26:925-933. doi: 10.1111/j.1468-2982.2006.01137.x
60. Birk S, Kruuse C, Petersen KA, Tfelt-Hansen P, Olesen J (2006) The headache-inducing effect of cilostazol in human volunteers. Cephalalgia 26:1304-1309. doi: 10.1111/j.1468-2982.2006.01218.x
61. Birk S, Petersen KA, Kruuse C, Guieu R, Jonassen O, Eisert W, Olesen J (2005) The effect of circulating adenosine on cerebral haemodynamics and headache generation in healthy subjects. Cephalalgia 25:369-377. doi: 10.1111/j.1468-2982.2005.00867.x
62. Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28:226-236. doi: 10.1111/j.1468-2982.2007.01497.x
63. Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16-25. doi: 10.1093/brain/awn307
64. Schytz HW, Wienecke T, Oturai PS, Olesen J, Ashina M (2009) The cholinomimetic agent carbachol induces headache in healthy subjects. Cephalalgia 29:258-268. doi: 10.1111/j.1468-2982.2008.01715.x
65. Petersen KA, Birk S, Kitamura K, Olesen J (2009) Effect of adrenomedullin on the cerebral circulation: Relevance to primary headache disorders. Cephalalgia 29:23-30. doi: 10.1111/ j.1468-2982.2008.01695.x
66. Lassen LH, Christiansen I, Iversen HK, Jansen-Olesen I, Olesen J (2003) The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Cephalalgia 23:877-886. doi: 10.1046/j.1468-2982.2003.00586.x
67. Burnstein R, Jakubowski M (2005) Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol 493:9-14. doi: 10.1002/cne.20688
68. Hansen JM, Petersen J, Wienecke T, Olsen KS, Jensen LT, Ashina M (2009) Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers. J Headache Pain 10:85-91. doi: 10.1007/s10194-009-0102-x
69. Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL (1997) Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat-intravital microscope studies. Cephalalgia 17:525-531. doi: 10.1046/j.1468-2982.1997.1704525.x
70. Munoz-Islas E, Gupta S, Jimenez-Mena LR, Lozano-Cuenca J, Sanchez-Lopez A, Centurion D, Mehrotra S, Maassen Van Den Brink A, Villalon CM (2006) Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT 1B rather 5-HT 1D receptors. Br J Pharmacol 149:82-91. doi: 10.1038/sj.bjp.0706839
71. Sheykhzade M, Nyborg NC (2004) Homologous desensitization of calcitonin gene-related peptide-induced relaxation in rat intramural coronary arteries. Eur J Pharmacol 484:91-101. doi: 10.1016/j.ejphar.2003.10.052
72. Ebersberger A, Ringkamp M, Reeh PW, Handwerker HO (1997) Recording from brain stem neurons responding to chemical stimulation of subarachnoid space. J Neurophysiol 77:3122-3133
73. Edvinsson L, Tfelt-Hansen P (2008) The blood-brain barrier in migraine treatment. Cephalalgia 28:1245-1258. doi: 10.1111/ j.1468-2982.2008.01675.x
74. Suzuki R, Rygh LJ, Dickenson AH (2004) Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25:613-617. doi: 10.1016/j.tips.2004.10.002
75. Mason P (2005) Deconstructing endogenous pain modulation. J Neurophysiol 94:1659-1663. doi: 10.1152/jn.00249.2005
76. Benarroch EE (2008) Descending monoaminergic pain modulation: Bidirectional control and clinical relevance. Neurology 71:217-221. doi: 10.1212/01.wnl.0000318225.51122.63
77. Carlson JD, Maire JJ, Martenson ME, Heinricher MM (2007) Sensitization of pain-modulating neurons in the rostral ventromedial medulla after peripheral nerve injury. J Neurosci 27:13222-13231. doi: 10.1523/ JNEUROSCI.3715-07.2007
78. Zhao Z-Q, Chiechio S, Sun Y-G, Zhang K-H, Zhao C-S, Scott M, Johnson RL, Deneris ES, Renner KJ, RW Gereau IV, Chen Z-F (2007) Mice lacking central serotonergic neurons show enhanced inflammatory pain and an impaired analgesic response to antidepressant drugs. J Neurosci 27:6045-6053. doi: 10.1523/JNEUROSCI.1623-07.2007
79. Zhao Z-Q, Gao Y-J, Sun Y-G, Zhao C-S, Gereau RW IV, Chen Z-F (2007) Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward. Proc Natl Acad Sci USA 104:14519-14524. doi: 10.1073/pnas.0705740104
80. Moja PL, Cusi C, Sterzi RR, Canepari C (2007) Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headache (review). The Cochrane Library 4:1-50
81. Sicuteri F, Boccuni M, Fanciullacci M, Gatto G (1983) Naloxone effectiveness on spontaneous and induced perceptive disorders in migraine. Headache 23:179-183. doi: 10.1111/j.1526-4610.1983.hed2304179.x
82. Nicolodi M (1996) Differential sensitivity to morphine challenge in migraine sufferers and headache-exempt subjects. Cephalalgia 16:297-304. doi: 10.1046/j.1468-2982.1996.1605297.x
83. Saper JR, Lake AE III (2008) Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: Limited efficacy, risks, and proposed guidelines. Headache 48:838-849. doi: 10.1111/ j.1526-4610.2008.01153.x
84. Panconesi A, Anselmi B, Franchi G (1995) Increased adverse effects of opiates in migraine patients. Cephalalgia 15:159-160
85. Friedman BW, Kapoor A, Friedman MS, Hochberg ML, Rowe BH (2008) The relative efficacy of meperidine for the treatment of acute migraine: A meta-analysis of randomized controlled trials. Ann Emerg Med 52:705-713. doi: 10.1016/j.annemergmed.2008.05.036
86. Ross JR, Riley J, Taegetmeyer AB, Sato H, Gretton S, du Bois RM, Welsh KI (2008) Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects. Cancer 112:1390-1403. doi: 10.1002/cncr.23292
87. Coppola G, Pierelli F, Schoenen J (2008) Habituation and migraine. Neurobiol Learn Mem. doi: 10.1016/j.nlm.2008.07.006
88. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, Coenen HH, Diener HC (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658-660. doi: 10.1038/nm0795-658
89. Bahra A, Matharu MS, Buchel C, Franckowiak RS, Goadsby PJ (2001) Brainstem activation specific to migraine headache. Lancet 357:1016-1017. doi: 10.1016/S0140-6736(00)04250-1
90. Afridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RSJ, Goadsby PJ (2005) A positron enission tomographic study in spontaneous migraine. Arch Neurol 62:1270-1275. doi: 10.1001/archneur.62.8.1270
91. Sakai Y, Dobson C, Diksic M, Aubè M, Hamel E (2008) Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology 70:431-439. doi: 10.1212/01.wnl.0000299095.65331.6f
92. 1A receptors binding in migraine without aura: A 18 F-MPPF-PET study. Cephalalgia 28:1282-1291. doi: 10.1111/j.1468-2982.2008.01677.x
93. De Tommaso M, Lo Sito L, Di Fruscolo O, Sardaro M, Prudenzano MP, Lamberti P, Livrea P (2005) Lack of habituation of nociceptive evoked responses and pain sensitivity during migraine attack. Clin Neurophysiol 116:1254-1264. doi: 10.1016/j.clinph.2005.02.018
94. Bingel U, Schoell E, Herken W, Buchel C, May A (2007) Habituation to painful stimulation involves the antinociceptive system. Pain 131:21-30. doi: 10.1016/j.pain.2006.12.005
95. Moulton EA, Burstein R, Tully S, Hargreaves R, Becerra L, Borsook D (2008) Interictal dysfunction of a brainstem descending modulatory center in migraine patients. PLoS ONE. doi: 10.1371/journal.pone.0003799
96. Brighina F, Palermo A, Fierro B (2009) Cortical inhibition and habituation to evoked potentials: Relevance for pathophysiology of migraine. J Headache Pain 10:77-84. doi: 10.1007/s10194-008-0095-x
97. Goadsby PJ (2007) Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 13:39-44. doi: 10.1016/ j.molmed.2006.11.005
98. Lambert GA, Hoskin KL, Zagami AS (2008) Cortico-NRM influences on trigeminal neuronal sensation. Cephalalgia 28:640-652. doi: 10.1111/ j.1468-2982.2008.01572.x
99. Dodick DW (2008) Examining the essence of migraine-Is it the blood vessel or the brain? A debate. Headache 48:661-667
100. Rothrock JF (2008) "Outside-In" vs "Inside-Out": revisiting migraine's vascular hypothesis. Headache 48:1409-1410. doi: 10.1111/j.1526-4610.2008.01276.x
101. Cutrer FM, Charles A (2008) The neurogenic basis of migraine. Headache 48:1411-1414. doi: 10.1111/j.1526-4610.2008.01277.x
102. Dahl E, Edvinsson L (1988) Anatomical organization of cerebral and extracerebral vasculature. In: Olesen J, Edvinsson L (eds) Basic mechanisms of headache. Elsevier, Amsterdam, pp 27-47